Detalhe da pesquisa
1.
Efficacy and safety of simeprevir with PegIFN/ribavirin in naïve or experienced patients infected with chronic HCV genotype 4.
J Hepatol
; 62(5): 1047-55, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25596313
2.
Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis.
Gastroenterology
; 147(1): 132-142.e4, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24704719
3.
Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study.
J Hepatol
; 61(4): 761-9, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24882048
4.
Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients.
Antimicrob Agents Chemother
; 58(9): 5332-41, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24982076
5.
Response-guided and -unguided treatment of chronic hepatitis C.
Liver Int
; 32 Suppl 1: 64-73, 2012 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-22212575
6.
Protease inhibitor-based triple therapy in chronic hepatitis C: guidelines by the French Association for the Study of the Liver.
Liver Int
; 32(10): 1477-92, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22891751
7.
Can We Predict Sustained Virologic Response to Interferon α Therapy in Patients With Chronic Hepatitis Delta Virus Infection?
Clin Gastroenterol Hepatol
; 13(13): 2350-2, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26254201
8.
Anti-E1E2 antibodies status prior therapy favors direct-acting antiviral treatment efficacy.
Clin Res Hepatol Gastroenterol
; 42(4): 313-318, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29551607
9.
Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.
Lancet Gastroenterol Hepatol
; 2(3): 177-188, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28404133
10.
Current treatments for chronic hepatitis B virus infections.
Curr Opin Virol
; 18: 109-16, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27318098
11.
Remodeling of B-Cell Subsets in Blood during Pegylated IFNα-2a Therapy in Patients with Chronic Hepatitis B Infection.
PLoS One
; 11(6): e0156200, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27281019
12.
Pegylated Interferon α-2a Triggers NK-Cell Functionality and Specific T-Cell Responses in Patients with Chronic HBV Infection without HBsAg Seroconversion.
PLoS One
; 11(6): e0158297, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27348813
13.
Early virological assessment during telaprevir- or boceprevir-based triple therapy in hepatitis C cirrhotic patients who failed a previous interferon based regimen - The ANRS CO20-CUPIC study.
Clin Res Hepatol Gastroenterol
; 39(4): 443-50, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25636238
14.
Simeprevir versus telaprevir with peginterferon and ribavirin in previous null or partial responders with chronic hepatitis C virus genotype 1 infection (ATTAIN): a randomised, double-blind, non-inferiority phase 3 trial.
Lancet Infect Dis
; 15(1): 27-35, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25482330
15.
Faldaprevir (BI 201335), deleobuvir (BI 207127) and ribavirin oral therapy for treatment-naive HCV genotype 1: SOUND-C1 final results.
Antivir Ther
; 18(8): 1015-9, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23558093
16.
[Current data on the treatment of chronic hepatitis B]. / Données actuelles sur le traitement de l'hépatite B chronique.
Presse Med
; 37(2 Pt 2): 287-93, 2008 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-18042341
17.
Intrafamilial prevalence of hepatitis B virus in Western Brazilian Amazon region: epidemiologic and biomolecular study.
J Gastroenterol Hepatol
; 21(5): 863-8, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16704537